Search results
Results from the WOW.Com Content Network
Cyproheptadine, sold under the brand name Periactin among others, is a first-generation antihistamine with additional anticholinergic, antiserotonergic, and local anesthetic properties. It was patented in 1959 and came into medical use in 1961. [ 5 ]
In one study, 14 children with abdominal migraine were administered pizotifen syrup, a serotonin and histamine antagonist. After four months, 70% of the patients said their symptoms had improved. Their symptoms were noticeably milder and less frequent. [30] Propranolol and cyproheptadine syrup were found to alleviate symptoms in a retrospective ...
Apetamin is a potentially dangerous figure-augmentation product. [1] [2] It is a syrup containing cyproheptadine, the amino acid lysine, and some vitamins.Cyproheptadine, the active ingredient, is an antihistamine and a hepatotoxin that has many effects on the body, including increased appetite, fatigue, and drowsiness. [3]
While pizotifen is effective in adults, [2] evidence of efficacy in children is limited, [3] and its use is limited by side effects, principally drowsiness and weight gain, and it is usually not the first choice medicine for preventing migraines, instead being used as an alternative when other drugs have failed to be effective. [4]
Rupatadine fumarate has been approved for the treatment of allergic rhinitis and chronic urticaria in adults and children over 12 years. It is available as round, light salmon coloured tablets containing 10 mg of rupatadine (as fumarate) to be administered orally, once a day.
Clemastine is an antihistamine with anticholinergic and sedative effects. Antihistamines competitively bind to histamine receptor sites, thus reducing the neurotransmitter's effects. [9]
“Adults who grew up as only children tend to be more mature based on adult attention and interactions that were not divided among other siblings,” Dr. Brown observes. 2. Independence
This is a list of investigational attention deficit hyperactivity disorder drugs, or drugs that are currently under development for clinical use in the treatment of attention deficit hyperactivity disorder (ADHD) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in ...